Aigen Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Aigen Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,116	Closed	-$329K	–	575
2025 Q4	$329K	Buy	+7,116	New	+$298K	0.08%	337
2025 Q1	–	Sell	-8,042	Closed	-$230K	–	800
2024 Q4	$230K	Buy	+8,042	New	+$266K	0.04%	565
2024 Q1	–	Sell	-10,994	Closed	-$338K	–	725
2023 Q4	$338K	Buy	+10,994	New	+$275K	0.06%	452
2020 Q2	–	Sell	-657	Closed	-$11K	–	899
2020 Q1	$11K	Sell	657 -16,271	-96%	-$336K	﹤0.01%	1140
2019 Q4	$348K	Buy	+16,928	New	+$282K	0.06%	401

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Aigen Investment Management's COLL Position: Q1 2026 in Review

Aigen Investment Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 7,116 shares — an estimated $329K sold.

Aigen Investment Management first reported a position in COLL in Q4 2019 and held it in 5 quarters. The position peaked at $348K in Q4 2019. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Aigen Investment Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Aigen Investment Management sold 7,116 Collegium Pharmaceutical shares in Q1 2026, an estimated $329K.
Aigen Investment Management first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 5 quarters.
Aigen Investment Management's Collegium Pharmaceutical position peaked at $348K in Q4 2019.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.